However, the prognostic value of aberrations in ERG [19] and other ETS genes is still inconclusive, which is best explained by the lack of sufficiently large studies accounting for the common multifocality and heterogeneity of prostate cancer. This evidence concerns the gene ERG and prostate carcinoma.